Shanthi Ganesh

Title: Innovations of Shanthi Ganesh in Cancer Treatment

Introduction

Shanthi Ganesh is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative research and patents. With a total of three patents to his name, his work focuses on utilizing the Seneca Valley virus for therapeutic purposes.

Latest Patents

Ganesh's latest patents revolve around the Seneca Valley virus (SVV), a novel RNA picornavirus. The inventions provide isolated SVV nucleic acids and proteins encoded by these nucleic acids. Additionally, the patents include antibodies raised against SVV proteins. Notably, SVV has the ability to selectively kill certain types of tumors, leading to methods for using SVV and its polypeptides in cancer treatment. The inventions also detail methods for detecting cancer using SVV nucleic acids and proteins. Furthermore, they explore the creation of new oncolytic virus derivatives and the alteration of viruses to target specific tumors.

Career Highlights

Throughout his career, Shanthi Ganesh has worked with prominent companies such as Novartis AG. His experience in the pharmaceutical industry has greatly influenced his research and innovations in cancer therapies.

Collaborations

Ganesh has collaborated with notable colleagues, including Paul Hallenbeck and Laura M. Hales, who have contributed to his research endeavors.

Conclusion

Shanthi Ganesh's innovative work with the Seneca Valley virus represents a promising advancement in cancer treatment. His patents and collaborations highlight his commitment to improving therapeutic options for patients.